Ypsomed AG, a leading Swiss company headquartered in Burgdorf, Switzerland (CH), has established itself as a prominent player in the medical technology industry since its founding in 1984. Specialising in the development and manufacturing of innovative drug delivery systems, Ypsomed focuses on providing solutions for diabetes management and other chronic conditions. With a strong presence in Europe and expanding operations in Asia and North America, Ypsomed is renowned for its unique products, including the YpsoPump® and the mylife™ Diabetescare range. These offerings are distinguished by their user-friendly design and advanced technology, catering to the needs of patients and healthcare professionals alike. Ypsomed's commitment to quality and innovation has solidified its market position, making it a trusted partner for pharmaceutical companies and healthcare providers worldwide.
How does Ypsomed Ag's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ypsomed Ag's score of 79 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ypsomed Ag, headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Ypsomed Holding AG, which may influence its climate commitments and emissions reporting. As of now, Ypsomed Ag has not publicly disclosed any reduction targets or specific climate initiatives. The absence of documented emissions data and reduction targets suggests that the company may still be in the early stages of formalising its climate strategy. Ypsomed Holding AG, as the parent organisation, may have relevant climate commitments and emissions data that could impact Ypsomed Ag's sustainability efforts. However, specific figures or targets from Ypsomed Holding AG have not been provided in the current context. In summary, while Ypsomed Ag is part of a larger corporate structure that may have climate initiatives, there is currently no available emissions data or defined reduction targets for the company itself.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 
| Scope 2 | - | - | 00,000 | - | 0,000 | 00,000 | - | 
| Scope 3 | - | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 
Ypsomed Ag's Scope 3 emissions, which increased by 11% last year and increased by approximately 11% since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 50% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ypsomed Ag has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.